EGFR and breast carcinoma: Collectively, these data suggest that enhanced pSmad3L through BLT1-NOX-ROS-EGFR-PI3K-ERK1/2-linked signaling cascade as a critical mechanism for the resistance of breast cancer cells to TGF-β1-induced growth inhibition.